Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts:Randomized Comparative Trial.

Launched by ASSIUT UNIVERSITY · May 7, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at two different ways to treat common warts: using a cream called imiquimod 5% along with cryotherapy (a freezing treatment), compared to using either treatment on its own. The goal is to see which method works better at getting rid of warts and how safe each option is. The study is designed for adults over 18 years old who have been diagnosed with common warts.

If you decide to participate, you will be randomly assigned to one of the treatment groups. This means you might receive the combination treatment or one treatment alone, and your progress will be monitored closely. However, people who are pregnant, have weakened immune systems, or certain medical conditions might not be eligible to join. The trial has not started recruiting participants yet, but it aims to better understand how to effectively treat warts using these methods.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with common warts diagnosed clinically and by dermoscopy.
• • Patients older than 18years old.
• Exclusion Criteria:
• • Pregnancy and lactation.
• • Immunosuppression or being under any kind of treatment causing
• • absolute or relative immunosuppression.
• • Patients with chronic systemic diseases.
• • All cases of bleeding tendency or using anticoagulants.
• • Concurrent use of systemic or topical treatments of warts in the last 4 weeks.